Education
About Us
Working with TipRanks
Follow Us
Inmode (INMD)
:INMD
INMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$13.14 - $19.85
Previous CloseN/A
Volume968.14K
Average Volume (3M)1.12M
Market Cap
$998.17M
Enterprise Value$414.34M
Total Cash (Recent Filing)$510.68M
Total Debt (Recent Filing)$6.10M
Price to Earnings (P/E)5.8
Beta1.33
Next Earnings
Oct 22, 2025EPS Estimate
0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.47
Shares Outstanding69,558,670
10 Day Avg. Volume1,139,894
30 Day Avg. Volume1,117,137
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.42
Enterprise Value/Revenue1.03
Enterprise Value/Gross Profit1.29
Enterprise Value/Ebitda3.36
Forecast
1Y Price Target
$17.17Price Target Upside19.65% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
Bulls Say, Bears Say
Bulls Say
Global ExpansionINMD is expanding global direct operations and launching new platforms across both noninvasive aesthetics and clinical areas.
Product DemandThe strong traction seen with the CO2 laser and consideration of further laser procedures strengthens INMD's ability to be a one-stop-shop for providers.
Bears Say
Market ChallengesInMode faces persistent headwinds with a preliminary miss and guidance cut, indicating challenges in the market.
Revenue GuidanceThe company lowered its FY25 revenue guidance to $365M-$375M from $395M-$405M.
InMode News
INMD FAQ
What was Inmode’s price range in the past 12 months?
Inmode lowest stock price was $13.14 and its highest was $19.85 in the past 12 months.
What is Inmode’s market cap?
Inmode’s market cap is $998.17M.
When is Inmode’s upcoming earnings report date?
Inmode’s upcoming earnings report date is Oct 22, 2025 which is in 65 days.
How were Inmode’s earnings last quarter?
Inmode released its earnings results on Jul 30, 2025. The company reported $0.47 earnings per share for the quarter, beating the consensus estimate of $0.411 by $0.059.
Is Inmode overvalued?
According to Wall Street analysts Inmode’s price is currently Undervalued.
Does Inmode pay dividends?
Inmode does not currently pay dividends.
What is Inmode’s EPS estimate?
Inmode’s EPS estimate is 0.34.
How many shares outstanding does Inmode have?
Inmode has 69,558,670 shares outstanding.
What happened to Inmode’s price movement after its last earnings report?
Inmode reported an EPS of $0.47 in its last earnings report, beating expectations of $0.411. Following the earnings report the stock price went down -2.865%.
Which hedge fund is a major shareholder of Inmode?
Currently, no hedge funds are holding shares in INMD
InMode Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$17.17 (19.65% Upside)
$17.17 (19.65% Upside)
Blogger Sentiment
Bullish
INMD Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 2.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.4%
Last 30 Days <0.1%
Last 30 Days <0.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-10.20%
12-Months-Change
Fundamentals
Return on Equity
25.91%
Trailing 12-Months
Asset Growth
-17.62%
Trailing 12-Months
Company Description
Inmode
InMode Ltd. is a global provider of innovative and minimally invasive aesthetic and medical technologies. The company specializes in devices that utilize radiofrequency (RF) technology to perform various aesthetic procedures, including body contouring, facial rejuvenation, and hair removal. InMode operates primarily in the aesthetic medicine sector, offering a range of products designed for plastic surgeons, dermatologists, and other medical professionals. Its core products include the BodyTite, FaceTite, and Morpheus8 platforms, which enhance both surgical and non-surgical treatment options for patients seeking cosmetic improvements.
INMD Company Deck
INMD Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong international growth and maintained high margins, but was overshadowed by challenges in the North American market, increased operating expenses, reduced guidance, and the impact of U.S. tariffs. The sentiment reflects a cautious outlook due to these challenges.View all INMD earnings summariesINMD Stock 12 Month Forecast
Average Price Target
$17.17
▲(19.65% Upside)
Technical Analysis
Ownership Overview
―
Insiders
9.05% Mutual Funds
25.16% Other Institutional Investors
63.15% Public Companies and Individual Investors